東方電氣(01072.HK)向主要股東出售東樹新材52.46%股權
東方電氣(01072.HK)公布,公司主要股東東方電氣集團,與公司擁有其95.45%權益的東汽有限簽訂了增資協議。東方電氣集團同意向東樹新材以現金注資1.5億元人民幣。增資完成後,東樹新材的股東
益比例將分別為東方電氣集團52.46%及東汽有限47.54%,東樹新材將不再是公司之間接附屬。
公司初步評估因增資協議導致視作出售間接附屬公司而錄得非現金收益約2,513.19萬元人民幣。
東樹新材主要從事合成材料製造,複合材料、2-(口夫)喃甲醇、糠醛、膠黏劑、環氧樹脂及固化劑、粘接劑、水性塗料、鑄造材料、導電漿料、金屬加工輔助材料、包裝材料、專用化學品製造等業務。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.